1. Barnes, D.M. (1988) ‘New data intensify agony over ecstasy’, Science 239: 864–866.
2. Barnes, D.M. (1989) ‘Neurotoxicity creates regulatory dilemma’, Science 243: 29–30.
3. Battaglia, G., Yeh, S.Y., and De Souza, E.B. (1988) ‘MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons’, Pharmac. Biochem. Behav. 29: 269–274.
4. Battaglia, G., Yeh, S.Y., O’Hearn, E., Molliver, M.E., Kuhar, M.J., and De Souza, E.B. (1987) ‘3,4-methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of 3H -paroxetine-labeled serotonin uptake sites’, J. Pharmacol. Exp. Ther. 242: 911–916.
5. Breese, G.R. (1975) ‘Chemical and immunochemical lesions by specific neurotoxic substances and antisera’, in L.L. Iversen et al. (eds.), Handbook of Psychopharmacology, Plenum, New York, pp. 137–189.